China NMPA Product Recall - Real-time dynamic blood glucose monitoring system

Medtronic MINIMED initiated a voluntary recall of its real-time continuous glucose monitoring systems, as reported on July 28, 2014, by its Chinese distributor, Medtronic (Shanghai) Management Co., Ltd. This recall, published by the National Medical Products Administration (NMPA) under index JGXX-2014-10083, addresses a potential compromise in the moisture resistance of specific serial numbers, including GLU122174U-GLU122699U and KIT371358U-KIT413818U. Should moisture infiltrate the device, it could result in display malfunctions or non-responsive buttons, potentially impacting effective diabetes management for adult patients. The affected products, registered with CFDA (Imported) 2011 No. 3213987, were explicitly confirmed as neither imported nor sold within the Chinese market. Consequently, no direct consumer actions are required in China. Medtronic has received no reports of injuries or adverse events linked to this issue. Following the recall notification, provincial and municipal food and drug administrations were instructed to enhance their oversight and management of similar medical devices. This proactive measure underscores Medtronic's dedication to product integrity and patient safety, aligning with regulatory standards even for products not distributed locally.